Stefan Schmidt, MD
Medical Doctor
Medical University Innsbruck
nternal Medicine V, Hematology and Oncology
Anichstrasse 35
Innsbruck
Austria
6020
Papers:
CHRONIC MYELOID LEUKEMIA TREATMENT: STARTING WITH A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB?